Key result
Virgin coconut oil supplementation for 4 weeks increased resting popliteal artery flow-mediated dilation from 4.9% to 5.5% (p<0.05) in healthy young adults.
Why the study?
Does virgin coconut oil supplementation improve resting popliteal artery flow-mediated dilation and hyperemic response to aerobic exercise in healthy young adults?
RCT (n=34)
Does virgin coconut oil supplementation improve resting popliteal artery flow-mediated dilation and hyperemic response to aerobic exercise in healthy young adults?
Short-term virgin coconut oil supplementation improves resting endothelial function as measured by flow-mediated dilation in healthy young adults, suggesting potential vascular benefits.
May enhance resting endothelial function in healthy adults; hypothesis-generating and requires RCTs before any practice implications.
Virgin coconut oil (VCO) is high in antioxidants (e.g., polyphenols) that may reduce reactive oxygen species‐induced conversion of vascular endothelial‐derived nitric oxide (NO) to toxic peroxynitrite. As such, flow‐mediated dilation (FMD, a surrogate marker of NO bioavailability) and exercise‐mediated hyperemia may be enhanced following short‐term VCO supplementation. However, these potential beneficial effects have never been assessed in humans. We tested the hypotheses that a 4 week VCO supplement (30 ml·day −1 ) would improve resting popliteal artery (PA) FMD and the hyperemic response to aerobic exercise. Thirty‐four young, healthy participants were divided into VCO (n=19, 10♂, 22±2 years, 24±3 kg·m −2 ), and Control (n=15, 10♂, 24±2 years, 24±3 kg·m −2 ) groups. PA‐FMD and PA blood flow were assessed via high‐resolution duplex ultrasonography (Vivid i, GE Healthcare) and analyzed using commercial software (Cardiovascular Suite, Quipu). After resting measurements, a 10‐minute bout of moderate‐intensity (60% heart rate reserve) cycling exercise was completed. PA blood flow was measured for 5‐minutes post‐exercise and total PA blood volume was calculated from the area under the curve. After 4 weeks, PA‐FMD increased (p < 0.05) following VCO supplementation (4.9±0.9% to 5.5±1.2%) with no change (p > 0.9) in the Control group (5.7±2.1% to 5.8±1.9%). There were no differences (both, p > 0.28) in post‐exercise total PA blood volumes in either group (VCO: 495±355 ml to 598±384 ml; Control: 562±362 ml to 488±229 ml). The increased FMD response observed in our young healthy adults suggests that short‐term VCO supplementation has potential as a dietary treatment for populations with elevated ROS levels and reduced vascular endothelial (e.g., older adults, smokers, etc.). However, additional research is required to test this hypothesis. Support or Funding Information Support provided by: Canadian Foundation for Innovation: Leaders Opportunity Fund, and a Faculty of Health Professions Research Development grant. SAR and MWO were recipients of a NS Graduate Scholarship. MWO was awarded a NSHRF Scotia Scholar Award and a Heart & Stroke BrightRed Award. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .
No takes yet. Share an insight, caveat, or question.
Robinson et al. (2018) conducted an RCT in Healthy young adults (n=34). Virgin coconut oil (VCO) vs. Control was evaluated on Resting popliteal artery flow-mediated dilation (PA-FMD) (p=< 0.05). Virgin coconut oil supplementation for 4 weeks increased resting popliteal artery flow-mediated dilation from 4.9% to 5.5% (p<0.05) in healthy young adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: